ArticleDiscover oncology2026

Predicting of survival in metastatic melanoma patients under anti-PD-1 monotherapy using genomic mutation and copy number variation.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.